Key result
Bioprosthetic valves show no difference versus mechanical in survival or events after tricuspid valve replacement.
Why the study?
Does bioprosthetic tricuspid valve replacement improve clinical outcomes compared to mechanical valves in patients requiring tricuspid valve replacement?
Cohort (n=104)
Does bioprosthetic tricuspid valve replacement improve clinical outcomes compared to mechanical valves in patients requiring tricuspid valve replacement?
Bioprosthetic and mechanical tricuspid valves demonstrate similar long-term survival and valve-related events, though their modes of failure differ, with bioprostheses failing more predictably.
Answers are grounded in this paper and cite their sources.
Supports equivalent bioprosthetic or mechanical valve selection after tricuspid replacement; leaves open randomized trials to confirm given high perioperative mortality.
Significant morbidity and mortality is associated with tricuspid valve replacement, and controversy still exists as to the ideal prosthesis in this position. This study aimed to identify the risk factors for low cardiac output and mortality, and whether bioprosthetic or mechanical valves perform better in the tricuspid position. Results of 121 tricuspid valve replacements in 104 patients between January 1966 and December 2002 were reviewed. Most patients were in New York Heart Association functional class III or IV. Perioperative mortality was 19%. On multivariate analysis, age and preoperative jaundice were significant predictors of low cardiac output; age, jaundice, atrial fibrillation, and bypass time were significant predictors of mortality. Mechanical valves were significantly more prone to thromboembolism, whereas bioprostheses suffered structural valve deterioration. There were no significant differences in anticoagulation or bleeding episodes between the two groups, nor in valve-related events, deaths, and long term survival. There was no significant difference in performance so as to recommend one type over the other, but bioprosthetic valves may be more favorable as they fail predictably.
No takes yet. Share an insight, caveat, or question.
Solomon et al. (2004) conducted a cohort in Tricuspid valve replacement (n=104). Bioprosthetic valve vs. Mechanical valve was evaluated on Valve-related events, deaths, and long term survival. Bioprosthetic and mechanical valves showed no significant differences in valve-related events or survival after tricuspid valve replacement, which had an overall perioperative mortality of 19%.
Synapse has enriched 10 related papers. Consider them for comparative context: